Literature DB >> 15449463

Review: pathology of variant Creutzfeldt-Jakob disease.

Alexander H Peden1, James W Ironside.   

Abstract

Variant Creutzfeldt-Jakob disease (vCJD) is a novel human prion disease that results from exposure to the bovine spongiform encephalopathy (BSE) agent, probably by the oral route. The pathological features of vCJD are unique, with extensive involvement of lymphoid tissues in addition to the central nervous system. This article reviews the histopathology and biochemistry of vCJD, emphasising diagnostic features and indicating several areas of active research. The widespread distribution of infectivity in lymphoid tissues in vCJD has lead to concerns over the possibility of iatrogenic disease transmission by contaminate surgical instruments, or by blood transfusion. vCJD has so far only occurred in individuals within a genetic subset defined by the natural polymorphism at codon 129 in the prion protein gene. It remains uncertain if this disease will occur in other genetic subgroups within the population. Continuing surveillance of vCJD in the UK and other countries in which BSE has been identified will be necessary for future estimations of disease numbers worldwide.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15449463

Source DB:  PubMed          Journal:  Folia Neuropathol        ISSN: 1509-572X            Impact factor:   2.038


  7 in total

1.  Generation of novel neuroinvasive prions following intravenous challenge.

Authors:  Patricia Aguilar-Calvo; Cyrus Bett; Alejandro M Sevillano; Timothy D Kurt; Jessica Lawrence; Katrin Soldau; Per Hammarström; K Peter R Nilsson; Christina J Sigurdson
Journal:  Brain Pathol       Date:  2018-07-05       Impact factor: 6.508

Review 2.  Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples.

Authors:  Douglas B Kell
Journal:  Arch Toxicol       Date:  2010-08-17       Impact factor: 5.153

3.  Factors affecting the accuracy of urine-based biomarkers of BSE.

Authors:  Margot Plews; Lise Lamoureux; Sharon Lr Simon; Catherine Graham; Viola Ruddat; Stefanie Czub; J David Knox
Journal:  Proteome Sci       Date:  2011-02-07       Impact factor: 2.480

4.  All clinically-relevant blood components transmit prion disease following a single blood transfusion: a sheep model of vCJD.

Authors:  Sandra McCutcheon; Anthony Richard Alejo Blanco; E Fiona Houston; Christopher de Wolf; Boon Chin Tan; Antony Smith; Martin H Groschup; Nora Hunter; Valerie S Hornsey; Ian R MacGregor; Christopher V Prowse; Marc Turner; Jean C Manson
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

5.  The identification of disease-induced biomarkers in the urine of BSE infected cattle.

Authors:  Sharon L R Simon; Lise Lamoureux; Margot Plews; Michael Stobart; Jillian LeMaistre; Ute Ziegler; Catherine Graham; Stefanie Czub; Martin Groschup; J David Knox
Journal:  Proteome Sci       Date:  2008-09-05       Impact factor: 2.480

Review 6.  Molecular pathology of human prion diseases.

Authors:  Gabor G Kovacs; Herbert Budka
Journal:  Int J Mol Sci       Date:  2009-03-09       Impact factor: 5.923

Review 7.  Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine.

Authors:  Gabor G Kovacs
Journal:  Int J Mol Sci       Date:  2016-02-02       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.